GlassScriptPhysician profile
Thomas M Harvey
NPI 1457353435
$22,544.75
in general payments reported to CMS, 2019-2025
26 companies · $2,013 in 2025
The $2,013 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $6,777 · 2021: $1,356 · 2022: $7,939 · 2023: $997 · 2024: $2,064 · 2025: $2,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604 · Consulting Fee: $2,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.03 |
| Consulting Fee | $2,470.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $14,256.60 | 2020-2025 | Callisto Eye, Cirrus Hd-Oct, Visumax |
| Johnson & Johnson Surgical Vision, INC. | $2,510.01 | 2021-2024 | Tecnis Simplicity, Ifs Advanced Femtosec Laser, Intralase Fs Femtosec Laser |
| Alcon Vision LLC | $1,299.81 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Topcon Healthcare, INC. | $1,000.00 | 2022 | |
| Lensar, INC. | $721.83 | 2019-2024 | Lensar Laser System |
| New World Medical,INC. | $535.29 | 2019-2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Allergan, INC. | $361.91 | 2019-2020 | |
| Abbvie INC. | $308.01 | 2023-2025 | |
| Glaukos Corporation | $268.10 | 2021-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite |
| Carl Zeiss Meditec USA, INC. | $210.46 | 2023 | Quatera 700, Iolmaster 700 |
| Rxsight INC | $189.08 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $139.31 | 2024 | Oxervate |
| Rayner Intraocular Lenses Limited | $131.37 | 2022-2024 | Rayone Aspheric, Rayone Emv, Omidria |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $102.08 | 2019-2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $77.04 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Cameron-Ehlen Group, INC. | $76.73 | 2019 | |
| Sun Pharmaceutical Industries INC. | $75.58 | 2019-2023 | Cequa |
| Eyepoint US, INC. | $58.05 | 2019 | |
| Bausch & Lomb Americas INC. | $42.47 | 2022 | |
| Ocular Therapeutix, INC. | $37.83 | 2020-2023 | Dextenza |
| Omeros Corporation | $37.09 | 2019-2021 | |
| Align Ophthalmics LLC | $32.66 | 2024 | |
| Aerie Pharmaceuticals, INC. | $30.08 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.01 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.18 | 2023 | |
| Sight Sciences, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.